Dr. Danielle O. Castillo, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 446
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
VA license 0101250053 -
Internal Medicine Physician
VA license 0101250053 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sentara Norfolk General Hospital Norfolk, VA
- Sentara Leigh Hospital Norfolk, VA
- Sentara Virginia Beach General Hospital Virginia Beach, VA
- Chesapeake General Hospital Chesapeake, VA
- The Outer Banks Hospital, Inc Nags Head, NC
Medical groups
- Bayview Physician Services PC (310 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 446
- Services billed
- 14,788
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 2,280 | 23 |
| Established patient office or other outpatient visit, 30-39 minutes | 592 | 341 |
| Blood glucose (sugar) test performed by hand-held instrument | 284 | 142 |
| Hemoglobin a1c level | 215 | 116 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 113 | 59 |
| Injection of drug or substance under skin or into muscle | 98 | 30 |
| Established patient office or other outpatient visit, 20-29 minutes | 83 | 71 |
| New patient office or other outpatient visit, 45-59 minutes | 71 | 71 |
| Ultrasound scan of head and neck soft tissue | 54 | 53 |
| Administration of influenza virus vaccine | 23 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Chesapeake, VA | 279 |
| Ozempic (semaglutide) Other prescribers in Chesapeake, VA | 122 |
| Alendronate Sodium Other prescribers in Chesapeake, VA | 95 |
| Synthroid (levothyroxine sodium) Other prescribers in Chesapeake, VA | 75 |
| Methimazole Other prescribers in Chesapeake, VA | 58 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Chesapeake, VA | 58 |
| Mounjaro (tirzepatide) Other prescribers in Chesapeake, VA | 49 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Chesapeake, VA | 47 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in Chesapeake, VA | 47 |
| Metformin Hcl Other prescribers in Chesapeake, VA | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 105 payments worth $2,275 in total to this clinician.
| Corcept Therapeutics | $337 |
|---|---|
| Mannkind Corporation | $183 |
| Amgen Inc. | $180 |
| AbbVie Inc. | $164 |
| Novo Nordisk Inc | $161 |
| Ascendis Pharma Endocrinology Inc | $159 |
| Radius Health, Inc. | $155 |
| Bayer HealthCare Pharmaceuticals Inc. | $119 |
| Food and Beverage | $2,275 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.